362 related articles for article (PubMed ID: 17013898)
1. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.
Park HW; Kang HC; Kim IJ; Jang SG; Kim K; Yoon HJ; Jeong SY; Park JG
Int J Cancer; 2007 Jan; 120(1):7-12. PubMed ID: 17013898
[TBL] [Abstract][Full Text] [Related]
2. CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations.
Hesson LB; Wilson R; Morton D; Adams C; Walker M; Maher ER; Latif F
Oncogene; 2005 Jun; 24(24):3987-94. PubMed ID: 15806169
[TBL] [Abstract][Full Text] [Related]
3. Frequent involvement of ras-signalling pathways in both polypoid-type and flat-type early-stage colorectal cancers.
Noda H; Kato Y; Yoshikawa H; Arai M; Togashi K; Nagai H; Konishi F; Miki Y
J Exp Clin Cancer Res; 2006 Jun; 25(2):235-42. PubMed ID: 16918136
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation.
Nagasaka T; Sasamoto H; Notohara K; Cullings HM; Takeda M; Kimura K; Kambara T; MacPhee DG; Young J; Leggett BA; Jass JR; Tanaka N; Matsubara N
J Clin Oncol; 2004 Nov; 22(22):4584-94. PubMed ID: 15542810
[TBL] [Abstract][Full Text] [Related]
5. BRAF/K-ras mutation, microsatellite instability, and promoter hypermethylation of hMLH1/MGMT in human gastric carcinomas.
Wu M; Semba S; Oue N; Ikehara N; Yasui W; Yokozaki H
Gastric Cancer; 2004; 7(4):246-53. PubMed ID: 15616773
[TBL] [Abstract][Full Text] [Related]
6. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.
Bagci B; Sari M; Karadayi K; Turan M; Ozdemir O; Bagci G
Cancer Biomark; 2016 Jun; 17(2):133-43. PubMed ID: 27540971
[TBL] [Abstract][Full Text] [Related]
7. RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma.
Kang S; Lee JM; Jeon ES; Lee S; Kim H; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
Int J Cancer; 2006 Sep; 119(6):1316-21. PubMed ID: 16619251
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
Zhang Z; Sun D; Van do N; Tang A; Hu L; Huang G
Int J Cancer; 2007 Jan; 120(1):32-8. PubMed ID: 17013896
[TBL] [Abstract][Full Text] [Related]
9. K-ras mutations and RASSF1A promoter methylation in colorectal cancer.
van Engeland M; Roemen GM; Brink M; Pachen MM; Weijenberg MP; de Bruïne AP; Arends JW; van den Brandt PA; de Goeij AF; Herman JG
Oncogene; 2002 May; 21(23):3792-5. PubMed ID: 12032847
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features.
Harada K; Hiraoka S; Kato J; Horii J; Fujita H; Sakaguchi K; Shiratori Y
Br J Cancer; 2007 Nov; 97(10):1425-31. PubMed ID: 17923875
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
Zlobec I; Bihl MP; Schwarb H; Terracciano L; Lugli A
Int J Cancer; 2010 Jul; 127(2):367-80. PubMed ID: 19908233
[TBL] [Abstract][Full Text] [Related]
12. Methylation of RASSF1A, RASSF2A, and HIN-1 is associated with poor outcome after radiotherapy, but not surgery, in oral squamous cell carcinoma.
Huang KH; Huang SF; Chen IH; Liao CT; Wang HM; Hsieh LL
Clin Cancer Res; 2009 Jun; 15(12):4174-80. PubMed ID: 19509163
[TBL] [Abstract][Full Text] [Related]
13. Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.
Oliveira C; Velho S; Domingo E; Preto A; Hofstra RM; Hamelin R; Yamamoto H; Seruca R; Schwartz S
Oncogene; 2005 Nov; 24(51):7630-4. PubMed ID: 16007118
[TBL] [Abstract][Full Text] [Related]
14. The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer.
Akino K; Toyota M; Suzuki H; Mita H; Sasaki Y; Ohe-Toyota M; Issa JP; Hinoda Y; Imai K; Tokino T
Gastroenterology; 2005 Jul; 129(1):156-69. PubMed ID: 16012945
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.
Esteller M; Toyota M; Sanchez-Cespedes M; Capella G; Peinado MA; Watkins DN; Issa JP; Sidransky D; Baylin SB; Herman JG
Cancer Res; 2000 May; 60(9):2368-71. PubMed ID: 10811111
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the BRAF gene in colorectal mucinous carcinoma in association with histological configuration.
Yoshitake N; Fujii S; Mukawa K; Tominaga K; Fukui H; Ichikawa K; Tomita S; Ono Y; Imai Y; Terano A; Hiraishi H; Fujimori T
Oncol Rep; 2007 Jan; 17(1):9-15. PubMed ID: 17143472
[TBL] [Abstract][Full Text] [Related]
17. Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation.
Gröschl B; Bettstetter M; Giedl C; Woenckhaus M; Edmonston T; Hofstädter F; Dietmaier W
Int J Cancer; 2013 Apr; 132(7):1537-46. PubMed ID: 22965873
[TBL] [Abstract][Full Text] [Related]
18. Aberrant promoter methylation and silencing of RASSF2A gene in cervical cancer.
Zhang X; Ma Y; Wu Y; Lin L; Ma X; Zhang Y
J Obstet Gynaecol Res; 2014 May; 40(5):1375-81. PubMed ID: 24605823
[TBL] [Abstract][Full Text] [Related]
19. Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma.
de Maat MF; Narita N; Benard A; Yoshimura T; Kuo C; Tollenaar RA; de Miranda NF; Turner RR; van de Velde CJ; Morreau H; Hoon DS
Am J Pathol; 2010 Nov; 177(5):2347-56. PubMed ID: 20952593
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
